Psychedelic Shares Surge as Trump Speeds FDA Reviews

Shares of psychedelic drug developers rose in premarket trading on Monday after President Donald Trump signed an executive order directing health regulators to speed up reviews of psychedelic drugs and boosted federal research funding.Shares of Atai Life Sciences jumped…[#item_full_content]

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.